Goff Hill Limited is on the leading edge of investigations associated with the vast amounts of accumulated data on molecular structures and creative use of information regarding chemical molecules and biological macromolecules. The strategic scientific direction is focused on designing novel candidate pharmacologic agents for a wide range of disorders including primary brain cancers, multiple sclerosis, various viral infections, as well as other neurological diseases.
RECENT NEWS: "THE PATHOPHYSIOLOGY OF THE MEASLES VIRUS IN INFECTIOUS DISEASE" by William G. Tucker, MD is being presented for publication. This is the Scientific presentation of the Etiology of Multiple Sclerosis.
PRESS RELEASE: GOFF HILL LIMITED , a Pharmaceutical Research Development Company, announces the exciting NEW CANCER DRUG that causes the Cancer Tumor Cells to completely disintegrate with one five (5) day treatment.
 | PRESS_RELEASE.pdf |